Post
of 18,736
$CBIS Through this limited release of unisex regimens to self-medicating patients, they expect to track the use of these products through the dispensary, and observe the effectiveness of this particular formulation and delivery system.
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!